Other

Stock Repurchased During Period Shares

Vertex Pharmaceuticals Stock Repurchased During Period Shares remained flat by 0.0% to $1.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 77.8%, from $675.00K to $1.20M. Over 2 years (FY 2023 to FY 2025), Stock Repurchased During Period Shares shows an upward trend with a 92.2% CAGR.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
Metric ID: other_stock_repurchased_during_period_shares

Historical Data

3 years
 FY'23FY'24FY'25
Value$1.30M$2.70M$4.80M
YoY Change—+107.7%+77.8%
Range$1.30M – $4.80M
CAGR+92.2%
Avg YoY Growth+92.7%
Median YoY Growth+92.7%
Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's stock repurchased during period shares?
Vertex Pharmaceuticals (VRTX) reported stock repurchased during period shares of $1.20M in Q4 2025.
How has Vertex Pharmaceuticals's stock repurchased during period shares changed year-over-year?
Vertex Pharmaceuticals's stock repurchased during period shares increased by 77.8% year-over-year, from $675.00K to $1.20M.
What is the long-term trend for Vertex Pharmaceuticals's stock repurchased during period shares?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's stock repurchased during period shares has grown at a 92.2% compound annual growth rate (CAGR), from $1.30M to $4.80M.